BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for John L Higgins. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at John L Higgins har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TECH / Bio-Techne Corporation Director 65.236
US:OABI / OmniAb, Inc. Director 2.851.887
US:LGND / Ligand Pharmaceuticals Incorporated Director 417.695
US:BCRX / BioCryst Pharmaceuticals, Inc. Director 15.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af John L Higgins. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BCRX / BioCryst Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BCRX / BioCryst Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Insidersalg BCRX / BioCryst Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BCRX / BioCryst Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af John L Higgins som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-11 2025-08-07 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.040 65.236 8,37 21,84 110.074 1.424.754
2025-06-18 2025-06-17 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 20.000 2.851.887 0,71
2025-05-13 2025-05-12 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 65.000 2.831.887 2,35 1,44 93.600 4.077.917
2025-05-05 2025-05-01 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 12.000 60.196 24,90 21,84 262.080 1.314.681
2025-03-21 2025-03-21 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 4.000 2.766.887 0,14 2,28 9.120 6.308.502
2025-03-20 2025-03-20 4 OABI OmniAb, Inc.
Common Stock
P - Purchase 125.750 2.762.887 4,77 2,35 295.512 6.492.784
2025-01-30 2025-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.172 2.637.137 0,50
2024-10-28 2024-10-24 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.462 48.196 3,13
2024-09-16 2024-09-12 4 TECH BIO-TECHNE Corp
Common Stock
F - Taxes -1.874 46.734 -3,86 73,20 -137.177 3.420.929
2024-09-16 2024-09-12 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 6.000 48.608 14,08 22,95 137.700 1.115.554
2024-07-10 2024-07-08 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 6.000 42.608 16,39 22,95 137.700 977.854
2024-06-21 2024-06-18 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 20.000 2.623.965 0,77
2024-05-16 2024-05-14 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -4.000 36.608 -9,85 83,84 -335.377 3.069.372
2024-05-16 2024-05-14 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 4.000 40.608 10,93 22,95 91.800 931.954
2024-04-23 2022-11-01 4/A OABI OmniAb, Inc.
Common Stock
A - Award 2.427.861 2.603.965 1.378,65
2024-01-31 2024-01-30 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 13.173 2.352.625 0,56
2023-10-30 2023-10-26 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.625 36.608 4,65
2023-06-27 2023-01-04 4 OABI OmniAb, Inc.
Common Stock
F - Taxes 57.803 2.339.452 2,53 3,23 186.704 7.556.430
2023-06-27 2022-12-28 4 OABI OmniAb, Inc.
Common Stock
F - Taxes 25.914 2.397.255 1,09 3,66 94.845 8.773.953
2023-05-25 2023-05-23 4 OABI OmniAb, Inc.
Common Stock
S - Sale -9.000 2.462.686 -0,36 4,05 -36.450 9.973.878
2023-05-25 2023-05-23 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 9.000 2.471.686 0,37 3,68 33.120 9.095.804
2023-05-23 2023-05-19 4 OABI OmniAb, Inc.
Common Stock
S - Sale -1.000 2.462.686 -0,04 4,05 -4.050 9.973.878
2023-05-23 2023-05-19 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 1.000 2.463.686 0,04 3,68 3.680 9.066.364
2023-05-19 2023-05-18 4 OABI OmniAb, Inc.
Common Stock
S - Sale -50.000 2.462.686 -1,99 3,89 -194.500 9.579.849
2023-05-19 2023-05-18 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 50.000 2.512.686 2,03 3,68 184.000 9.246.684
2023-05-02 2023-04-28 4 TECH BIO-TECHNE Corp
Common Stock
F - Taxes -4.377 34.983 -11,12 79,88 -349.635 2.794.442
2023-05-02 2023-04-28 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 16.000 39.360 68,49 21,85 349.600 860.016
2023-02-01 2023-01-30 4 OABI OmniAb, Inc.
Common Stock
A - Award 39.517 2.462.686 1,63
2022-12-30 2022-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5.289 417.695 -1,25 66,29 -350.608 27.689.002
2022-12-20 2022-12-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 422.984 -2,31 61,87 -618.657 26.168.201
2022-12-14 2022-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -3.944 432.984 -0,90 64,80 -255.571 28.057.363
2022-12-14 2022-12-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 436.928 4,80 12,78 255.600 5.583.940
2022-12-01 2022-11-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -9.803 416.928 -2,30 72,90 -714.639 30.394.051
2022-11-21 2022-11-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 426.731 2,40 12,78 127.800 5.453.622
2022-11-21 2022-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 416.731 -2,34 78,32 -783.173 32.637.247
2022-11-03 2022-11-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 45.922 424.731 12,12
2022-11-03 2022-11-02 4 OABI OmniAb, Inc.
Common Stock
M - Exercise 246.648 2.423.169 11,33 2,52 621.553 6.106.386
2022-11-03 2022-11-01 4 OABI OmniAb, Inc.
Common Stock
A - Award 2.176.521 2.176.521
2022-10-31 2022-10-27 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 338 5.840 6,14
2022-09-22 2022-09-16 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1.000 366.180 -0,27 88,06 -88.060 32.245.811
2022-09-16 2022-09-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 364.180 -0,82 89,35 -268.050 32.539.483
2022-09-16 2022-09-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2.000 367.180 -0,54 90,00 -180.000 33.046.200
2022-08-12 2022-08-11 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -8 5.502 -0,15 380,71 -3.046 2.094.666
2022-08-12 2022-08-11 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -504 5.510 -8,38 385,47 -194.277 2.123.936
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -992 6.014 -14,16 380,15 -377.112 2.286.240
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -100 7.006 -1,41 374,90 -37.490 2.626.514
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -900 7.106 -11,24 373,99 -336.593 2.657.586
2022-08-12 2022-08-10 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 3.400 8.006 73,82 66,90 227.460 535.601
2022-07-06 2022-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 164 369.180 0,04 75,84 12.437 27.997.504
2022-06-14 2022-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 20.423 369.016 5,86
2022-06-09 2022-06-08 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -600 4.606 -11,53 366,09 -219.654 1.686.211
2022-06-09 2022-06-08 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 600 5.206 13,03 66,90 40.140 348.281
2022-06-09 2022-06-07 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1.000 4.606 -17,84 364,31 -364.310 1.678.012
2022-06-09 2022-06-07 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 1.000 5.606 21,71 66,90 66.900 375.041
2022-05-10 2022-05-10 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
S - Sale 429.159,38
2022-05-10 2022-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8.000 57.616 -12,19
2022-05-10 2022-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 8.000 348.593 2,35 21,92 175.360 7.641.159
2022-05-09 2022-05-05 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 76.478 76.478
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.916 340.593 -0,56 123,68 -236.971 42.124.542
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.061 342.509 -0,60 123,68 -254.904 42.361.513
2022-02-16 2022-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.946 344.570 -0,56 123,68 -240.681 42.616.418
2022-02-07 2021-11-15 5 LGND LIGAND PHARMACEUTICALS INC
Common Stock
G - Gift -2.502 332.593 -0,75
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -6.183 349.018 -1,74 113,68 -702.883 39.676.366
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.060 355.201 -0,85 113,68 -347.861 40.379.250
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13.560 358.261 3,93
2022-01-28 2022-01-26 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.606 344.701 2,87
2021-11-12 2021-11-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 335.095 -0,89 160,50 -481.500 53.782.748
2021-11-01 2021-10-28 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 633 633
2021-11-01 2021-10-28 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 194 4.606 4,40
2021-07-02 2021-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 247 338.095 0,07 85,91 21.220 29.045.572
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.061 337.848 -0,61 172,46 -355.440 58.265.266
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.947 339.909 -0,57 172,46 -335.780 58.620.706
2021-02-18 2021-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.204 341.856 -0,35 172,46 -207.642 58.956.486
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -54.666 14.334 -79,23
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -60.000 0 -100,00
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.970 343.060 -0,86 203,03 -602.999 69.651.472
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 60.000 346.030 20,98 10,05 603.000 3.477.602
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -54.666 286.030 -16,05 203,40 -11.119.239 58.179.417
2021-02-09 2021-02-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 54.666 340.696 19,11 14,47 791.017 4.929.871
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 25.113 25.113
2021-02-05 2021-02-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12.608 286.030 4,61
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -30.000 65.616 -31,38
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -40.000 69.000 -36,70
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 30.000 273.422 12,32 21,92 657.600 5.993.410
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -40.000 243.422 -14,11 182,00 -7.280.000 44.302.804
2021-01-27 2021-01-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 40.000 283.422 16,43 14,47 578.800 4.101.116
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -50.000 109.000 -31,45
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4.596 243.422 -1,85 156,01 -717.022 37.976.266
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.607 248.018 4,03
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.845 238.411 -1,18 156,01 -443.848 37.194.500
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.946 241.256 2,53
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -50.000 235.310 -17,52 159,00 -7.950.000 37.414.290
2021-01-27 2021-01-25 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 50.000 285.310 21,25 14,47 723.500 4.128.436
2021-01-05 2020-12-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 223 235.310 0,09 84,53 18.851 19.891.343
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14.657 60.000 -19,63
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.683 235.087 -0,71 87,52 -147.296 20.574.814
2020-12-09 2020-12-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 14.657 236.770 6,60 10,05 147.303 2.379.538
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -20.000 74.657 -21,13
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.458 222.113 -1,09 81,77 -200.991 18.162.180
2020-11-10 2020-11-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 224.571 9,78 10,05 201.000 2.256.939
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
M - Exercise -5.000 0 -100,00
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -3.100 4.412 -41,27 301,06 -933.301 1.328.297
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -450 7.512 -5,65 299,84 -134.928 2.252.392
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1.450 7.962 -15,41 298,98 -433.516 2.380.451
2020-11-10 2020-11-06 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.000 9.412 113,33 70,35 351.750 662.134
2020-11-02 2020-10-29 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
A - Award 1.507 1.507
2020-11-02 2020-10-29 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 391 4.412 9,72
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.165 54.226 -2,10
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.373 93.627 -1,45
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise -1.777 54.421 -3,16
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.373 204.571 0,68 74,42 102.179 15.224.174
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.777 203.198 0,88 56,26 99.974 11.431.919
2020-07-09 2020-07-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1.165 201.421 0,58 85,79 99.945 17.279.908
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.310 133.982 -0,97 120,86 -158.327 16.193.065
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.689 135.292 -1,23 120,86 -204.133 16.351.391
2020-04-24 2019-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.918 136.981 -1,38 120,86 -231.809 16.555.524
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.117 205.173 -1,02 97,23 -205.836 19.948.971
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.310 207.290 -0,63 97,23 -127.371 20.154.807
2020-02-18 2020-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.689 208.600 -0,80 97,23 -164.221 20.282.178
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -48.125 0 -100,00
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 60.886 60.886
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 13.559 210.289 6,89
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5.009 196.730 -2,48 95,68 -479.261 18.823.126
2020-02-18 2020-02-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 48.125 201.739 31,33 9,96 479.325 2.009.320
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -5.000 4.021 -55,43 205,23 -1.026.132 825.216
2020-02-14 2020-02-12 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.000 9.021 124,35 61,46 307.300 554.431
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.948 153.614 -1,88 105,87 -312.105 16.263.114
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5.946 156.562 3,95
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.801 150.616 -2,46 105,87 -402.412 15.945.716
2019-12-26 2019-12-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.668 154.417 5,23
2019-10-28 2019-10-24 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 2.011 2.011
2019-10-28 2019-10-24 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 495 4.021 14,04
2019-09-24 2019-09-19 4/A LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 988.468,75
2019-09-23 2019-09-19 4 LGND LIGAND PHARMACEUTICALS INC
0.75% Convertible Senior Notes due 2023
P - Purchase 841.250,00
2019-07-31 2019-07-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.850 146.749 1,28 95,45 176.582 14.007.192
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Stock Options (Right to buy)
M - Exercise -5.000 0 -100,00
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -5.000 3.526 -58,64 203,67 -1.018.346 718.137
2019-06-06 2019-06-04 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 5.000 8.526 141,80 63,03 315.150 537.394
2019-05-31 2019-05-31 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.000 144.899 0,69 108,20 108.202 15.678.362
2019-05-14 2019-05-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.500 143.899 1,77 113,50 283.750 16.332.536
2019-03-15 2019-03-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.500 141.399 1,80 114,29 285.725 16.160.492
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 58.596 58.596
2019-02-13 2019-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12.809 138.899 10,16
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.168 126.090 -2,45 111,78 -354.119 14.094.340
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.390 129.258 5,20
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3.597 122.868 -2,84 111,78 -402.073 13.734.185
2019-01-25 2019-01-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.256 126.465 6,09
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4.000 0 -100,00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -29.790 0 -100,00
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 29.790 119.209 33,32 16,14 480.811 1.924.033
2019-01-14 2019-01-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.000 89.419 4,68 16,14 64.560 1.443.223
2018-10-29 2018-10-25 4 TECH BIO-TECHNE Corp
Stock Options (Right to buy)
A - Award 1.898 1.898
2018-10-29 2018-10-25 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 514 3.526 17,07
2018-08-31 2018-08-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.500 85.419 -3,94 258,25 -903.875 22.059.457
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
M - Exercise -10.000 0 -100,00
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -10.000 3.012 -76,85 187,92 -1.879.173 566.007
2018-08-27 2018-08-23 4 TECH BIO-TECHNE Corp
Common Stock
M - Exercise 10.000 13.012 332,01 61,08 610.800 794.773
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -12.993 159.000 -7,55
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.993 88.919 -12,75 243,00 -3.157.299 21.607.317
2018-08-17 2018-08-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.993 101.912 14,61 14,47 188.009 1.474.667
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3.007 171.993 -1,72
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -21.507 88.919 -19,48 241,33 -5.190.261 21.458.724
2018-08-17 2018-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 3.007 110.426 2,80 14,47 43.511 1.597.864
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -12.405 29.790 -29,40
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.405 107.419 -10,35 179,97 -2.232.491 19.331.875
2018-05-15 2018-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.405 119.824 11,55 16,14 200.217 1.933.959
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.982 107.419 -2,70 165,87 -494.624 17.817.590
2018-03-06 2018-03-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.015 110.401 5,76
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 41.392 41.392
2018-03-06 2018-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7.928 104.386 8,22
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.689 96.458 -1,72 157,18 -265.477 15.161.268
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.918 98.147 -1,92 157,18 -301.471 15.426.745
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.635 100.065 -2,57 157,18 -414.169 15.728.217
2018-02-16 2018-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -9.000 102.700 -8,06 157,03 -1.413.279 16.127.084
2018-01-26 2018-01-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -22.500 111.700 -16,77 165,00 -3.712.500 18.430.500
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -16.249 42.195 -27,80
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -11.850 134.200 -8,11 151,92 -1.800.307 20.388.281
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -16.249 146.050 -10,01 155,00 -2.518.595 22.637.750
2018-01-22 2018-01-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 16.249 162.299 11,13 16,14 262.259 2.619.506
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -5.199 146.050 -3,44 138,66 -720.893 20.251.293
2017-12-29 2017-12-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.965 151.249 7,05
2017-11-20 2017-11-17 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2.258 141.284 -1,57 140,34 -316.888 19.827.797
2017-11-17 2017-11-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -5.269 143.542 -3,54 142,53 -750.991 20.459.041
2017-10-30 2017-10-26 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 3.125 3.125
2017-10-30 2017-10-26 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 739 3.012 32,51
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -11.384 0 -100,00
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.744 148.811 -1,16 143,04 -249.462 21.285.925
2017-10-17 2017-10-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 11.384 150.555 8,18 21,92 249.537 3.300.166
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5.000 0 -100,00
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -5.000 139.171 -3,47 130,00 -650.000 18.092.230
2017-09-06 2017-09-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.000 144.171 3,59 21,00 105.000 3.027.591
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -5.483 5.000 -52,30
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -5.483 139.171 -3,79 125,00 -685.375 17.396.375
2017-08-10 2017-08-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5.483 144.654 3,94 21,00 115.143 3.037.734
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
M - Exercise X -4.666 0 -100,00
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4.666 139.171 -3,24 120,00 -559.920 16.700.520
2017-06-23 2017-06-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 4.666 143.837 3,35 21,00 97.986 3.020.577
2017-06-23 2008-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 4.666 4.666
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise X -12.000 10.483 -53,37
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -12.000 139.171 -7,94 114,87 -1.378.440 15.986.573
2017-06-09 2017-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 12.000 151.171 8,62 21,00 252.000 3.174.591
2017-03-21 2017-03-20 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -4.000 139.171 -2,79 109,10 -436.400 15.183.556
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -15.675 0 -100,00
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1.473 143.171 -1,02 106,92 -157.493 15.307.843
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 15.675 144.644 12,15 10,05 157.534 1.453.672
2017-03-10 2017-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.000 128.969 -3,01 107,06 -428.240 13.807.421
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 43.646 43.646
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 10.224 132.969 8,33
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4.783 122.745 -3,75 100,38 -480.118 12.321.143
2017-02-28 2017-02-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 9.168 127.528 7,75
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.019 118.360 -1,68 104,28 -210.541 12.342.581
2017-02-28 2017-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.285 120.379 -1,86 104,28 -238.280 12.553.122
2016-10-31 2016-10-27 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 3.985 3.985
2016-10-31 2016-10-27 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 914 2.273 67,26
2016-09-23 2016-09-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.000 122.664 -2,39 117,34 -352.020 14.393.394
2016-09-12 2016-09-08 4 TECH BIO-TECHNE Corp
Common Stock
S - Sale -1.700 1.359 -55,57 109,83 -186.716 149.263
2016-03-09 2016-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -6.000 22.483 -21,07
2016-03-09 2016-03-08 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.000 125.664 5,01 21,00 126.000 2.638.944
2016-03-09 2016-03-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -556 119.664 -0,46 102,97 -57.251 12.321.802
2016-03-09 2016-03-07 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10.277 120.220 -7,88 102,44 -1.052.776 12.315.337
2016-02-16 2016-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2.492 130.497 -1,87 85,97 -214.237 11.218.827
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 55.391 55.391
2016-02-16 2016-02-11 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 11.611 132.989 9,57
2015-11-02 2015-10-29 4 TECH BIO-TECHNE Corp
Stock Option (Right to Buy)
A - Award 4.260 4.260
2015-11-02 2015-10-29 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.059 3.059 52,95
2015-08-07 2015-08-06 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -4.666 121.378 -3,70 110,79 -516.946 13.447.469
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -500 126.044 -0,40 95,06 -47.530 11.981.743
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -3.300 126.544 -2,54 93,21 -307.593 11.795.166
2015-06-11 2015-06-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -6.200 129.844 -4,56 92,53 -573.686 12.014.465
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 56.198 56.198 56,26 3.161.699 3.161.699
2015-02-11 2015-02-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 15.945 136.044 13,28
2014-11-03 2014-10-30 4 TECH BIO-TECHNE Corp
Stock Option (right to buy)
A - Award 4.000 4.000
2014-11-03 2014-10-30 4 TECH BIO-TECHNE Corp
Common Stock
A - Award 1.000 2.000 100,00
2014-08-15 2014-08-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.000 120.099 0,84 54,97 54.970 6.601.842
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -16.875 48.125 -25,96
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.000 95.000 11,76 74,42 744.200 7.069.900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 10.000 95.000 11,76 74,42 744.200 7.069.900
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 75.000 75.000 74,42 5.581.500 5.581.500
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8.000 119.099 7,20
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -16.875 111.099 -13,19 75,00 -1.265.625 8.332.425
2014-02-14 2014-02-12 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 16.875 127.974 15,19 9,96 168.075 1.274.621
2014-01-21 2014-01-21 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -9.000 28.483 -24,01 21,00 -189.000 598.143
2014-01-21 2014-01-21 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 9.000 111.099 8,81 21,00 189.000 2.333.079
2014-01-21 2014-01-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -15.000 102.099 -12,81 64,00 -960.000 6.534.336
2013-11-04 2013-10-31 4 TECH TECHNE CORP /MN/
Stock Option
A - Award 4.000 4.000
2013-11-04 2013-10-31 4 TECH TECHNE CORP /MN/
Common Stock
A - Award 1.000 1.000
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -5.850 37.483 -13,50
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -4.668 15.675 -22,95
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 4.668 117.099 4,15 10,05 46.913 1.176.845
2013-10-22 2013-10-22 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 5.850 112.431 5,49 21,00 122.850 2.361.051
2013-10-22 2013-10-18 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -10.000 106.581 -8,58 55,00 -550.000 5.861.955
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -6.556 58.444 -10,09
2013-08-20 2013-08-19 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 6.556 116.581 5,96 16,14 105.814 1.881.617
2013-08-20 2013-08-16 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10.000 110.025 -8,33 42,85 -428.500 4.714.571
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 14.334 14.334 32,00 458.688 458.688
2013-06-04 2013-06-03 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 12.000 120.025 11,11
2013-06-04 2012-02-09 4/A LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 160.666 160.666 14,47 2.324.837 2.324.837
2013-06-04 2012-02-09 4/A LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6.000 95.275 6,72
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 95.616 95.616 21,92 2.095.903 2.095.903
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
A - Award 11.384 11.384 21,92 249.537 249.537
2013-02-19 2013-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8.000 120.025 7,14
2012-12-05 2012-12-05 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 2.000 112.025 1,82 18,03 36.060 2.019.811
2012-10-26 2012-10-25 4 TECH TECHNE CORP /MN/
Stock Option
A - Award 5.000 5.000
2012-08-14 2012-08-13 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 500 110.025 0,46 16,39 8.195 1.803.310
2012-07-03 2012-06-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 1.250 109.525 1,15 10,12 12.654 1.108.776
2012-05-25 2012-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Automatic Stock Option Grant
A - Award 15.000 15.000
2012-05-08 2012-05-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
P - Purchase 1.000 108.275 0,93 12,04 12.040 1.303.631
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 175.000 175.000 14,47 2.532.250 2.532.250
2012-02-13 2012-02-09 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 18.000 107.275 20,16
2012-01-06 2011-12-30 4 LGNDD LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 210 89.275 0,24 10,09 2.119 900.740
2004-05-18 3/A BCRX BIOCRYST PHARMACEUTICALS INC
None
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)